On Friday Zydus Cadila’s three-dose Covid-19 vaccine was granted emergency use authorisation for use in adults and children above 12 years, making it potentially the first vaccine to be administered to the adolescent population in India.
India reported 30,948 new cases of coronavirus on Saturday, August 21, 2021. Active cases declined to 3.53 lakh. Due to this, the country’s overall caseload has increased to over 3.24 crore. Kerala state reported 17,106 cases while Maharashtra reported 4,575 cases. More than 3.24 crore people have so far been found to be infected.
As same as the past few weeks, the state of Kerala remained the largest contributor with 17,106 new cases, while Maharashtra state recorded 4,575 cases. The death toll has increased to 4.34 lakh with 403 new fatalities.
The Zydus Group got emergency use approval on Friday for the vaccine that can be used for ages 12 years and above. On Saturday it said, it hoped to make its vaccine available to institutions like schools and colleges, but the decision would finally depend on talks with the government and its requirements. It also said that if everything goes as planned, by middle or end of September, it could deliver the initial doses of ZyCoV-D.
Also read: Coronavirus Cases On The Rise Again, Kerala Accounts For 50% Of New Infections
In other news, Israelis aged 40 and over will be able to receive coronavirus vaccine booster shots starting this weekend, said the Health Minister Nitzan Horowitz as the country battles an increase in infections.
Initially, Israel was one of the first countries to launch a vaccination drive in mid-December through an agreement with Pfizer to obtain millions of paid vaccine doses in exchange for sharing data on their effectiveness.
The vaccine campaign of Israel was a success story that helped drastically reduce infections in the country of nine million.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
